The FinTech Hub
Source: Live Mint Sai Life Sciences IPO allotment: With the bidding period for Sai Life Sciences’ initial public offering (IPO) now closed, investors’ focus has turned to the allotment announcement, expected today, December 16. The IPO, which ran from December 11 to December 13, received an overall subscription of 10.27 times. The qualified institutional buyers…
Source: Live Mint Sai Life Sciences IPO: After three-day bidding for the initial public offering (IPO) of Sai Life Sciences Limited, applicants eagerly await the announcement of share allotment. In the wake of the ‘T+3’ listing rule, the public issue must be listed within three days post-listing. As bidding for the Sai Life Sciences IPO…
Source: Live Mint TPG-backed Sai Life Sciences IPO is scheduled to open for subscription tomorrow (Wednesday, December 11). The firm is a contract research, development, and manufacturing organisation (CRDMO) that focuses on innovation. Backed by the private equity giant TPG Capital, it provides comprehensive services throughout the entire drug discovery, development, and manufacturing process for…
Source: Live Mint The initial public offering (IPO) of Sai Life Sciences, a prominent player in small-molecule drug development and manufacturing, is scheduled to open on Wednesday, December 11, 2024, and close on Friday, December 13, 2024. The IPO consists of a fresh issue worth ₹950 crore and an offer for sale (OFS) of 3.81…
